PALIFERMIN Side Effects

6083140-3 | Erythema
on Feb 13, 2009 Female patient from UNITED STATES , 38 years of age, was treated with Palifermin (View Usage). Patient experienced the following unwanted or unexpected effects: erythema. Palifermin dosage: .

5700826-8 | Anorexia, Fatigue
Patient was taking Palifermin (View Usage). Patient had the following side effects: anorexia, fatigue on Mar 28, 2008 from BELGIUM Additional patient health information: Male patient , weighting 122.4 lb, was diagnosed with mucosal inflammation and. Palifermin dosage: . Patient was hospitalized.

5624476-7 | Hypersensitivity
Adverse event was reported on Jan 30, 2008 by a Female patient taking Palifermin (View Usage) (Dosage: ) was diagnosed with stomatitis and. Location: AUSTRALIA , weighting 167.8 lb, After Palifermin was administered, patient had the following side effects: hypersensitivity. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ).

5608514-3 | Hypersensitivity
on Jan 16, 2008 Female patient from AUSTRALIA , weighting 167.8 lb, was diagnosed with stomatitis and was treated with Palifermin (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity. Palifermin dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ).


5537332-X | Hypersensitivity
on Nov 26, 2007 Female patient from AUSTRALIA , weighting 167.8 lb, was diagnosed with stomatitis and was treated with Palifermin (View Usage). Patient had the following side effects: hypersensitivity. Palifermin dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ).

5423519-3 | Basal Cell Carcinoma
Patient was taking Palifermin (View Usage). After Palifermin was administered, patient had the following side effects: basal cell carcinoma on Aug 13, 2007 from UNITED STATES Additional patient health information: Male patient , 44 years of age, weighting 189.2 lb, was diagnosed with hiv infection (What is hiv infection?) and. Palifermin dosage: . During the same period patient was treated with RITALIN (View Ritalin Review and Ritalin Label ), PROPECIA (View Propecia Review and Propecia Label ), MINOCIN (View Minocin Review and Minocin Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), TRUVADA (View Truvada Review and Truvada Label ), TRIZIVIR (View Trizivir Review and Trizivir Label ). Patient was hospitalized.

5412363-9 | Laryngeal Cancer
Adverse event was reported on Aug 07, 2007 by a Male patient taking Palifermin (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , weighting 270.7 lb, Patient experienced the following unwanted or unexpected effects: laryngeal cancer. During the same period patient was treated with SUSTIVA (View Sustiva Review and Sustiva Label ), TRUVADA (View Truvada Review and Truvada Label ), DAPSONE (View Dapsone Review and Dapsone Label ), ACTOS (View Actos Review and Actos Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), TENORMIN (View Tenormin Review and Tenormin Label ), CRESTOR (View Crestor Review and Crestor Label ), ZAROXOLYN (View Zaroxolyn Review and Zaroxolyn Label ). Patient was hospitalized.

5322149-1 | Dermatitis Acneiform, Febrile Neutropenia, Gingivitis, Glossitis, Infection, Viral Pharyngitis
on May 02, 2007 Male patient from POLAND , 19 years of age, was diagnosed with mucosal inflammation and was treated with Palifermin (View Usage). Patient had the following side effects: dermatitis acneiform, febrile neutropenia, gingivitis, glossitis, infection (What is infection?), viral pharyngitis. Palifermin dosage: . During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), BUSULFAN (View Busulfan Review and Busulfan Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ATGAM (View Atgam Review and Atgam Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), TAZOCIN (LEDERLE) (View Tazocin (lederle) Review and Tazocin (lederle) Label ), MAXIPIME (View Maxipime Review and Maxipime Label ).

5268278-2 | Blister, Epidermolysis, Exfoliative Rash, Oedema, Palmar-plantar Erythrodysaesthesia Syndrome, Pruritus
on Mar 07, 2007 Female patient from NETHERLANDS , weighting 183.0 lb, was diagnosed with mucosal inflammation and was treated with Palifermin (View Usage). After Palifermin was administered, patient had the following side effects: blister, epidermolysis, exfoliative rash, oedema, palmar-plantar erythrodysaesthesia syndrome, pruritus. Palifermin dosage: . During the same period patient was treated with ARA C (View Ara-c Review and Ara-c Label ), CARMUSTINE (View Carmustine Review and Carmustine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), MELPHALAN (View Melphalan Review and Melphalan Label ). Patient was hospitalized.

5170386-1 | Bacteraemia, Burning Sensation, Capillary Leak Syndrome, Febrile Neutropenia, Fluid Retention, Hypersensitivity, Mucosal Inflammation, Rash, Stomatitis
Patient was taking Palifermin (View Usage). Patient experienced the following unwanted or unexpected effects: bacteraemia, burning sensation, capillary leak syndrome, febrile neutropenia, fluid retention, hypersensitivity, mucosal inflammation, rash (What is rash?), stomatitis on Jul 19, 2006 from BELGIUM Additional patient health information: Female patient , weighting 165.3 lb, was diagnosed with peripheral blood stem cell apheresis and. Palifermin dosage: . During the same period patient was treated with CARMUSTINE (View Carmustine Review and Carmustine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), TPN (View Tpn Review and Tpn Label ). Patient was hospitalized.

5122698-5 | Bacteraemia, Burning Sensation, Capillary Leak Syndrome, Febrile Neutropenia, Fluid Retention, Hypersensitivity, Mucosal Inflammation, Rash, Stomatitis
Adverse event was reported on Jul 19, 2006 by a Female patient taking Palifermin (View Usage) (Dosage: ) was diagnosed with peripheral blood stem cell apheresis and. Location: BELGIUM , weighting 165.3 lb, Patient had the following side effects: bacteraemia, burning sensation, capillary leak syndrome, febrile neutropenia, fluid retention, hypersensitivity, mucosal inflammation, rash (What is rash?), stomatitis. During the same period patient was treated with CARMUSTINE (View Carmustine Review and Carmustine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), TPN (View Tpn Review and Tpn Label ). Patient was hospitalized.

5078846-9 | Asthenia, Constipation, Dysarthria, Hypersensitivity, Nausea, Rectal Haemorrhage, Refusal Of Treatment By Patient, Tinnitus
on Jun 27, 2006 Male patient from UNITED STATES , weighting 202.2 lb, was diagnosed with stomatitis and was treated with Palifermin (View Usage). After Palifermin was administered, patient had the following side effects: asthenia, constipation (What is constipation?), dysarthria, hypersensitivity, nausea (What is nausea?), rectal haemorrhage, refusal of treatment by patient, tinnitus (What is tinnitus?). Palifermin dosage: . During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), VIBRAMYCIN (View Vibramycin Review and Vibramycin Label ), SUDAFED 12 HOUR (View Sudafed 12 Hour Review and Sudafed 12 Hour Label ), EQUATE (View Equate Review and Equate Label ), LORTAB (View Lortab Review and Lortab Label ), NEULASTA (View Neulasta Review and Neulasta Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ).

5078204-7 | Dermatitis Exfoliative, Face Oedema, Fluid Retention, Oedema Mucosal, Pain, Pruritus, Sodium Retention, Tongue Oedema, Vomiting
on Jun 01, 2006 Female patient from BELGIUM , weighting 110.2 lb, was diagnosed with mucosal inflammation and was treated with Palifermin (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, face oedema, fluid retention, oedema mucosal, pain (What is pain?), pruritus, sodium retention, tongue oedema, vomiting. Palifermin dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), TROPISETRON (View Tropisetron Review and Tropisetron Label ), ZOFRAN (View Zofran Review and Zofran Label ), LITICAN (View Litican Review and Litican Label ), TRANXENE (View Tranxene Review and Tranxene Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), POLARAMINE (View Polaramine Review and Polaramine Label ).

5078203-5 | Dermatitis Exfoliative, Oedema Peripheral, Pruritus, Tongue Disorder
Patient was taking Palifermin (View Usage). Patient had the following side effects: dermatitis exfoliative, oedema peripheral, pruritus, tongue disorder on Jun 01, 2006 from BELGIUM Additional patient health information: Male patient , weighting 167.6 lb, was diagnosed with mucosal inflammation and. Palifermin dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), TROPISETRON (View Tropisetron Review and Tropisetron Label ), ALIZAPRIDE (View Alizapride Review and Alizapride Label ), CLORAZEPATE (View Clorazepate Review and Clorazepate Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), OFLOXACINE (View Ofloxacine Review and Ofloxacine Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ).

5078201-1 | Cytomegalovirus Infection, Dermatitis Exfoliative, Fluid Retention, Oedema, Pruritus, Pyrexia, Rash
Adverse event was reported on Jun 01, 2006 by a Male patient taking Palifermin (View Usage) (Dosage: ) was diagnosed with mucosal inflammation and. Location: BELGIUM , weighting 123.5 lb, After Palifermin was administered, patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), dermatitis exfoliative, fluid retention, oedema, pruritus, pyrexia, rash (What is rash?). During the same period patient was treated with ARACYTIN (View Aracytin Review and Aracytin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CARMUSTINE (View Carmustine Review and Carmustine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ). Patient was hospitalized.

5067135-4 | Burning Sensation, Capillary Leak Syndrome, Fluid Retention, Hypersensitivity, Rash, Stomatitis
on Jul 19, 2006 Female patient from BELGIUM , weighting 165.3 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Palifermin (View Usage). Patient experienced the following unwanted or unexpected effects: burning sensation, capillary leak syndrome, fluid retention, hypersensitivity, rash (What is rash?), stomatitis. Palifermin dosage: . During the same period patient was treated with CARMUSTINE (View Carmustine Review and Carmustine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

5064446-3 | Hypersensitivity, Refusal Of Treatment By Patient
on Jun 27, 2006 Male patient from UNITED STATES , weighting 202.2 lb, was diagnosed with stomatitis and was treated with Palifermin (View Usage). Patient had the following side effects: hypersensitivity, refusal of treatment by patient. Palifermin dosage: . During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), VIBRAMYCIN (View Vibramycin Review and Vibramycin Label ), SUDAFED 12 HOUR (View Sudafed 12 Hour Review and Sudafed 12 Hour Label ), EQUATE (View Equate Review and Equate Label ), LORTAB (View Lortab Review and Lortab Label ), NEULASTA (View Neulasta Review and Neulasta Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ).

5060727-8 | Hypersensitivity
Patient was taking Palifermin (View Usage). After Palifermin was administered, patient had the following side effects: hypersensitivity on Jun 27, 2006 from UNITED STATES Additional patient health information: Male patient , weighting 202.2 lb, was diagnosed with stomatitis and. Palifermin dosage: . During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), VIBRAMYCIN (View Vibramycin Review and Vibramycin Label ), SUDAFED 12 HOUR (View Sudafed 12 Hour Review and Sudafed 12 Hour Label ), EQUATE (View Equate Review and Equate Label ), LORTAB (View Lortab Review and Lortab Label ), NEULASTA (View Neulasta Review and Neulasta Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ).

5051356-0 | Constipation, Hypersensitivity, Rectal Haemorrhage
Adverse event was reported on Jun 27, 2006 by a Male patient taking Palifermin (View Usage) (Dosage: ) was diagnosed with stomatitis and. Location: UNITED STATES , weighting 202.2 lb, Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), hypersensitivity, rectal haemorrhage. During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), VIBRAMYCIN (View Vibramycin Review and Vibramycin Label ), SUDAFED 12 HOUR (View Sudafed 12 Hour Review and Sudafed 12 Hour Label ), EQUATE (View Equate Review and Equate Label ), LORTAB (View Lortab Review and Lortab Label ), NEULASTA (View Neulasta Review and Neulasta Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ).

5045778-1 | Burning Sensation, Hypersensitivity
on Jun 27, 2006 Male patient from UNITED STATES , weighting 202.2 lb, was diagnosed with stomatitis and was treated with Palifermin (View Usage). Patient had the following side effects: burning sensation, hypersensitivity. Palifermin dosage: . During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), VIBRAMYCIN (View Vibramycin Review and Vibramycin Label ), SUDAFED 12 HOUR (View Sudafed 12 Hour Review and Sudafed 12 Hour Label ), EQUATE (View Equate Review and Equate Label ), LORTAB (View Lortab Review and Lortab Label ).

5033826-4 | Diarrhoea, Mucosal Inflammation, Mucosal Membrane Hyperplasia, Nasopharyngeal Disorder, Pharyngolaryngeal Pain, Rash Erythematous, Salivary Hypersecretion, Skin Hyperpigmentation
on Apr 28, 2006 Female patient from ITALY , weighting 119.0 lb, was diagnosed with mucosal inflammation and was treated with Palifermin (View Usage). After Palifermin was administered, patient had the following side effects: diarrhoea, mucosal inflammation, mucosal membrane hyperplasia, nasopharyngeal disorder, pharyngolaryngeal pain, rash erythematous, salivary hypersecretion, skin hyperpigmentation. Palifermin dosage: . During the same period patient was treated with MEPRAL (View Mepral Review and Mepral Label ). Patient was hospitalized and became disabled.

5024304-7 | Dermatitis Exfoliative, Fluid Retention, Oedema, Pruritus, Pyrexia
Patient was taking Palifermin (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, fluid retention, oedema, pruritus, pyrexia on Jun 01, 2006 from BELGIUM Additional patient health information: Male patient , weighting 123.5 lb, was diagnosed with mucosal inflammation and. Palifermin dosage: . During the same period patient was treated with ARACYTIN (View Aracytin Review and Aracytin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), POLARAMINE (View Polaramine Review and Polaramine Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ). Patient was hospitalized.

5024300-X | Dermatitis Exfoliative, Oedema Peripheral, Pruritus, Tongue Disorder
Adverse event was reported on Jun 01, 2006 by a Male patient taking Palifermin (View Usage) (Dosage: ) was diagnosed with mucosal inflammation and. Location: BELGIUM , weighting 167.6 lb, Patient had the following side effects: dermatitis exfoliative, oedema peripheral, pruritus, tongue disorder.

5024291-1 | Dermatitis Exfoliative, Face Oedema, Fluid Retention, Nausea, Oedema Mucosal, Pain, Pruritus, Sodium Retention, Tongue Oedema
on Jun 01, 2006 Female patient from BELGIUM , weighting 110.2 lb, was diagnosed with mucosal inflammation and was treated with Palifermin (View Usage). After Palifermin was administered, patient had the following side effects: dermatitis exfoliative, face oedema, fluid retention, nausea (What is nausea?), oedema mucosal, pain (What is pain?), pruritus, sodium retention, tongue oedema. Palifermin dosage: .

5008302-5 | Diarrhoea, Mucosal Inflammation, Mucosal Membrane Hyperplasia, Nasopharyngeal Disorder, Rash Erythematous, Salivary Hypersecretion, Skin Hyperpigmentation
on Apr 28, 2006 Female patient from ITALY , weighting 119.0 lb, was diagnosed with mucosal inflammation and was treated with Palifermin (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, mucosal inflammation, mucosal membrane hyperplasia, nasopharyngeal disorder, rash erythematous, salivary hypersecretion, skin hyperpigmentation. Palifermin dosage: . During the same period patient was treated with MEPRAL (View Mepral Review and Mepral Label ).

4996334-2 | Mucosal Membrane Hyperplasia, Rash Erythematous, Skin Hyperpigmentation
Patient was taking Palifermin (View Usage). Patient had the following side effects: mucosal membrane hyperplasia, rash erythematous, skin hyperpigmentation on Apr 28, 2006 from ITALY Additional patient health information: Female patient , weighting 119.0 lb, was diagnosed with mucosal inflammation and. Palifermin dosage: . During the same period patient was treated with MEPRAL (View Mepral Review and Mepral Label ).

4994436-8 | Renal Failure, Skin Oedema
Adverse event was reported on Mar 15, 2006 by a Female patient taking Palifermin (View Usage) (Dosage: ) was diagnosed with mucosal inflammation and. Location: PORTUGAL , weighting 282.2 lb, After Palifermin was administered, patient had the following side effects: renal failure, skin oedema. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), BCNU (View Bcnu Review and Bcnu Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ).

4993492-0 | Hypotension, Rash Pruritic, Skin Oedema, Syncope, Weight Increased
on Mar 14, 2006 Female patient from PORTUGAL , weighting 213.8 lb, was diagnosed with mucosal inflammation and was treated with Palifermin (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, rash pruritic, skin oedema, syncope, weight increased. Palifermin dosage: . During the same period patient was treated with BCNU (View Bcnu Review and Bcnu Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ).

4992436-5 | Gingival Disorder, Hyperchromasia, Tongue Disorder
on Mar 15, 2006 Female patient from ITALY , weighting 134.5 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Palifermin (View Usage). Patient had the following side effects: gingival disorder, hyperchromasia, tongue disorder. Palifermin dosage: . During the same period patient was treated with MEPRAL (View Mepral Review and Mepral Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ).

4974991-4 | Gingival Disorder, Hyperchromasia, Tongue Disorder
Patient was taking Palifermin (View Usage). After Palifermin was administered, patient had the following side effects: gingival disorder, hyperchromasia, tongue disorder on Mar 15, 2006 from ITALY Additional patient health information: Female patient , weighting 134.5 lb, was diagnosed with peripheral blood stem cell apheresis and. Palifermin dosage: . During the same period patient was treated with MEPRAL (View Mepral Review and Mepral Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ).

4955297-6 | Gingival Disorder, Hyperchromasia, Tongue Disorder
Adverse event was reported on Mar 15, 2006 by a Female patient taking Palifermin (View Usage) (Dosage: ) was diagnosed with peripheral blood stem cell apheresis and. Location: ITALY , weighting 134.5 lb, Patient experienced the following unwanted or unexpected effects: gingival disorder, hyperchromasia, tongue disorder. During the same period patient was treated with MEPRAL (View Mepral Review and Mepral Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ).

4955295-2 | Adenocarcinoma, Ascites, Constipation, Disease Progression, Metastases To Liver, Metastases To Lung, Muscular Weakness, Peritoneal Carcinoma, Vomiting
on Feb 10, 2006 Male patient from SWITZERLAND , weighting 136.7 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Palifermin (View Usage). Patient had the following side effects: adenocarcinoma, ascites, constipation (What is constipation?), disease progression, metastases to liver, metastases to lung, muscular weakness, peritoneal carcinoma, vomiting. Palifermin dosage: . During the same period patient was treated with BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), VALTREX (View Valtrex Review and Valtrex Label ), IMMUNOGLOBULINS (View Immunoglobulins Review and Immunoglobulins Label ), VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ). Patient was hospitalized.

4955294-0 | Renal Failure, Skin Oedema
on Mar 15, 2006 Female patient from PORTUGAL , weighting 282.2 lb, was treated with Palifermin (View Usage). After Palifermin was administered, patient had the following side effects: renal failure, skin oedema. Palifermin dosage: . During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), BCNU (View Bcnu Review and Bcnu Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ).

4954621-8 | Hypotension, Rash Pruritic, Skin Oedema, Syncope, Weight Increased
Patient was taking Palifermin (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, rash pruritic, skin oedema, syncope, weight increased on Mar 14, 2006 from PORTUGAL Additional patient health information: Female patient , weighting 213.8 lb, was diagnosed with mucosal inflammation and. Palifermin dosage: . During the same period patient was treated with BCNU (View Bcnu Review and Bcnu Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ).

4935598-8 | Adenocarcinoma, Ascites, Constipation, Disease Progression, Metastases To Lung, Peritoneal Carcinoma, Weight Decreased
Adverse event was reported on Feb 10, 2006 by a Male patient taking Palifermin (View Usage) (Dosage: ) was diagnosed with peripheral blood stem cell apheresis and. Location: SWITZERLAND , weighting 136.7 lb, Patient had the following side effects: adenocarcinoma, ascites, constipation (What is constipation?), disease progression, metastases to lung, peritoneal carcinoma, weight decreased.

4918434-5 | Adenocarcinoma, Ascites, Constipation, Disease Progression, Metastases To Lung, Peritoneal Carcinoma, Weight Decreased
on Feb 10, 2006 Male patient from SWITZERLAND , weighting 136.7 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Palifermin (View Usage). After Palifermin was administered, patient had the following side effects: adenocarcinoma, ascites, constipation (What is constipation?), disease progression, metastases to lung, peritoneal carcinoma, weight decreased. Palifermin dosage: .

4917128-X | Acute Respiratory Distress Syndrome, Candidiasis, Disease Progression, Disseminated Intravascular Coagulation, Erythema Multiforme, Febrile Neutropenia, Hodgkin's Disease, Hyperglycaemia, Hypoxia
on Nov 14, 2005 Male patient from UNITED STATES , weighting 194.0 lb, was diagnosed with mucosal inflammation and was treated with Palifermin (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, candidiasis, disease progression, disseminated intravascular coagulation, erythema multiforme, febrile neutropenia, hodgkin's disease (What is hodgkin's disease?), hyperglycaemia, hypoxia. Palifermin dosage: . During the same period patient was treated with FILGRASTIM (View Filgrastim Review and Filgrastim Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

4909045-6 | Convulsion, Dizziness, Grand Mal Convulsion, Hyperhidrosis, Loss Of Consciousness, Urinary Incontinence
Patient was taking Palifermin (View Usage). Patient had the following side effects: convulsion, dizziness (What is dizziness?), grand mal convulsion, hyperhidrosis, loss of consciousness, urinary incontinence (What is urinary incontinence?) on Jan 20, 2006 from UNITED STATES Additional patient health information: Male patient , weighting 161.2 lb, was diagnosed with mucosal inflammation and. Palifermin dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), PERCOCET (View Percocet Review and Percocet Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), SENOKOT (View Senokot Review and Senokot Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), THORAZINE (View Thorazine Review and Thorazine Label ), LACTULOSE (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

4897702-X | Diarrhoea, Oedema, Oedema Peripheral, Pruritus, Pyrexia, Rash, Skin Exfoliation
Adverse event was reported on Dec 19, 2005 by a Female patient taking Palifermin (View Usage) (Dosage: ) . Location: SWITZERLAND , weighting 105.8 lb, After Palifermin was administered, patient had the following side effects: diarrhoea, oedema, oedema peripheral, pruritus, pyrexia, rash (What is rash?), skin exfoliation. During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), MELPHALAN (View Melphalan Review and Melphalan Label ).

4879805-9 | Erythema, Face Oedema, Paraesthesia Oral, Pruritus, Rash, Swollen Tongue
on Jun 21, 2005 Female patient from BELGIUM , weighting 163.1 lb, was diagnosed with mucosal inflammation and was treated with Palifermin (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, face oedema, paraesthesia oral, pruritus, rash (What is rash?), swollen tongue. Palifermin dosage: . During the same period patient was treated with ZOVIRAX (View Zovirax Review and Zovirax Label ), ZOMETA (View Zometa Review and Zometa Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), KONAKION (View Konakion Review and Konakion Label ), NADROPARIN CALCIUM (View Nadroparin Calcium Review and Nadroparin Calcium Label ).

4866562-5 | Acute Respiratory Distress Syndrome, Candidiasis, Disease Progression, Disseminated Intravascular Coagulation, Febrile Neutropenia, Graft Versus Host Disease, Hodgkin's Disease, Hyperglycaemia, Hypotension
on Nov 14, 2005 Male patient from UNITED STATES , weighting 194.0 lb, was diagnosed with mucosal inflammation and was treated with Palifermin (View Usage). Patient had the following side effects: acute respiratory distress syndrome, candidiasis, disease progression, disseminated intravascular coagulation, febrile neutropenia, graft versus host disease, hodgkin's disease (What is hodgkin's disease?), hyperglycaemia, hypotension. Palifermin dosage: . During the same period patient was treated with FILGRASTIM (View Filgrastim Review and Filgrastim Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

4865366-7 | Diarrhoea, Oedema, Oedema Peripheral, Pruritus, Pyrexia, Rash, Skin Exfoliation
Patient was taking Palifermin (View Usage). After Palifermin was administered, patient had the following side effects: diarrhoea, oedema, oedema peripheral, pruritus, pyrexia, rash (What is rash?), skin exfoliation on Dec 19, 2005 from SWITZERLAND Additional patient health information: Female patient , weighting 105.8 lb, . Palifermin dosage: . During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), MELPHALAN (View Melphalan Review and Melphalan Label ).

4865352-7 | Headache, Somnolence
Adverse event was reported on Sep 14, 2005 by a Male patient taking Palifermin (View Usage) (Dosage: ) . Location: BELGIUM , weighting 166.0 lb, Patient experienced the following unwanted or unexpected effects: headache (What is headache?), somnolence. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), AMIKIN (View Amikin Review and Amikin Label ), CALCIUM SANDOZ (View Calcium-sandoz Review and Calcium-sandoz Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), FOLVITE (View Folvite Review and Folvite Label ), STILNOCT (View Stilnoct Review and Stilnoct Label ), MERONEM (View Meronem Review and Meronem Label ). Patient was hospitalized.

4850622-9 | Acute Respiratory Distress Syndrome, Aspiration, Blister, Dermatitis, Disseminated Intravascular Coagulation, Erythema Multiforme, Febrile Neutropenia, Hodgkin's Disease, Hypotension
on Nov 14, 2005 Male patient from UNITED STATES , weighting 194.0 lb, was diagnosed with mucosal inflammation and was treated with Palifermin (View Usage). Patient had the following side effects: acute respiratory distress syndrome, aspiration, blister, dermatitis, disseminated intravascular coagulation, erythema multiforme, febrile neutropenia, hodgkin's disease (What is hodgkin's disease?), hypotension. Palifermin dosage: . During the same period patient was treated with FILGRASTIM (View Filgrastim Review and Filgrastim Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ). Patient was hospitalized.

4839941-X | Acute Respiratory Distress Syndrome, Aspiration, Candidiasis, Disseminated Intravascular Coagulation, Erythema Multiforme, Febrile Neutropenia, Hodgkin's Disease, Hyperglycaemia, Hypoxia
on Nov 14, 2005 Male patient from UNITED STATES , weighting 194.0 lb, was diagnosed with mucosal inflammation and was treated with Palifermin (View Usage). After Palifermin was administered, patient had the following side effects: acute respiratory distress syndrome, aspiration, candidiasis, disseminated intravascular coagulation, erythema multiforme, febrile neutropenia, hodgkin's disease (What is hodgkin's disease?), hyperglycaemia, hypoxia. Palifermin dosage: . During the same period patient was treated with FILGRASTIM (View Filgrastim Review and Filgrastim Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ). Patient was hospitalized.

4837642-5 | Blister, Epidermolysis, Exfoliative Rash, Haematoma, Oedema, Palmar-plantar Erythrodysaesthesia Syndrome, Pruritus
Patient was taking Palifermin (View Usage). Patient experienced the following unwanted or unexpected effects: blister, epidermolysis, exfoliative rash, haematoma, oedema, palmar-plantar erythrodysaesthesia syndrome, pruritus on Oct 26, 2005 from NETHERLANDS Additional patient health information: Female patient , weighting 183.0 lb, was diagnosed with mucosal inflammation and. Palifermin dosage: . During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), CARMUSTINE (View Carmustine Review and Carmustine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), MELPHALAN (View Melphalan Review and Melphalan Label ). Patient was hospitalized.

4801578-6 | Headache, Somnolence
Adverse event was reported on Sep 14, 2005 by a Male patient taking Palifermin (View Usage) (Dosage: ) . Location: BELGIUM , weighting 166.0 lb, Patient had the following side effects: headache (What is headache?), somnolence. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), AMIKIN (View Amikin Review and Amikin Label ), CALCIUM SANDOZ (View Calcium-sandoz Review and Calcium-sandoz Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), FOLVITE (View Folvite Review and Folvite Label ), STILNOCT (View Stilnoct Review and Stilnoct Label ), MERONEM (View Meronem Review and Meronem Label ). Patient was hospitalized.

4785706-7 | Cough, Glossodynia, Hypergammaglobulinaemia, Lymphocytosis, Tongue Ulceration, Vomiting, Weight Decreased
on Sep 19, 2005 Male patient from NETHERLANDS , weighting 165.3 lb, was diagnosed with mucosal inflammation and was treated with Palifermin (View Usage). After Palifermin was administered, patient had the following side effects: cough, glossodynia, hypergammaglobulinaemia, lymphocytosis, tongue ulceration, vomiting, weight decreased. Palifermin dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PRIMPERAN INJ (View Primperan Inj Review and Primperan Inj Label ), CIPROXIN (View Ciproxin Review and Ciproxin Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ), NEXIUM (View Nexium Review and Nexium Label ), PENICILLIN (View Penicillin Review and Penicillin Label ), VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ).

4779765-5 | Headache, Somnolence
on Sep 14, 2005 Male patient from BELGIUM , weighting 166.0 lb, was treated with Palifermin (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), somnolence. Palifermin dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), AMIKIN (View Amikin Review and Amikin Label ), CALCIUM SANDOZ (View Calcium-sandoz Review and Calcium-sandoz Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), FOLVITE (View Folvite Review and Folvite Label ), STILNOCT (View Stilnoct Review and Stilnoct Label ), MERONEM (View Meronem Review and Meronem Label ). Patient was hospitalized.

4761390-3 | Dysphagia, Oedema Mucosal, Rash, Tongue Disorder
Patient was taking Palifermin (View Usage). Patient had the following side effects: dysphagia, oedema mucosal, rash (What is rash?), tongue disorder on Aug 12, 2005 from BELGIUM Additional patient health information: Female patient , weighting 121.3 lb, was diagnosed with mucosal inflammation and. Palifermin dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), CIPROXIN (View Ciproxin Review and Ciproxin Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ALIZAPRIDE (View Alizapride Review and Alizapride Label ), HEPARIN (View Heparin Review and Heparin Label ), TROPISETRON (View Tropisetron Review and Tropisetron Label ).